Junshi Biosciences Increases R&D Investment to Seek Growth
The domestic PD-1 market is highly competitive, and Junshi Biosciences (688180.SH), despite being the first domestic manufacturer of PD-1 monoclonal antibody drugs, is still in a continuous state of l...